Related Experiment Video
Updated: Oct 4, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Case of reversible Mobitz type II atrioventricular block after the use of injectable antipsychotics
Hisao Naono1,2, Ryuichiro Takeda3, Hiroyuki Masuyama4
1Social Medical Corporation Doshinkai Koga General Hospital Miyazaki City Japan.
Abstract:
Although Mobitz type II atrioventricular block is typically an arrhythmia arising from a permanent organic disorder of the His-Purkinje system, reversible factors should also be considered. Here, we report the association between a rare reversible Mobitz type II atrioventricular block and antipsychotic medication in a 75-year-old patient with schizophrenia.
Insights
Reversible Mobitz type II atrioventricular block, typically permanent, can be linked to antipsychotic drugs. This case highlights the importance of considering medication side effects in cardiac arrhythmias.
Area of Science:
- Cardiology
- Pharmacology
- Psychiatry
Background:
- Mobitz type II atrioventricular block is generally considered a consequence of irreversible His-Purkinje system disease.
- Reversible causes of atrioventricular block are less commonly recognized but clinically significant.
Observation:
- A 75-year-old patient diagnosed with schizophrenia presented with Mobitz type II atrioventricular block.
- The patient was undergoing treatment with antipsychotic medication.
Findings:
- A rare association was identified between the patient's Mobitz type II atrioventricular block and the use of antipsychotic medication.
- This suggests a potential reversible etiology for the atrioventricular block, contrary to its typical permanent nature.
Implications:
- Clinicians should consider medication-induced cardiac side effects, including antipsychotics, when evaluating Mobitz type II atrioventricular block.
- Identifying reversible factors can lead to improved patient management and potentially avoid unnecessary invasive procedures.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Drugs Acting on Autonomic Ganglia: Blockers
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents

